Association Between Superoxide Dismutase Isoenzyme Gene Expression and Total Antioxidant Status in Patients with an End-Stage Renal Disease

被引:10
作者
Ninic, Ana [1 ]
Sopic, Miron [1 ]
Munjas, Jelena [1 ]
Spasojevic-Kalimanovska, Vesna [1 ]
Kotur-Stevuljevic, Jelena [1 ]
Bogavac-Stanojevic, Natasa [1 ]
Ivanisevic, Jasmina [1 ]
Simic-Ogrizovic, Sanja [2 ,3 ]
Kravljaca, Milica [2 ]
Jelic-Ivanovic, Zorana [1 ]
机构
[1] Univ Belgrade, Fac Pharm, Dept Med Biochem, Belgrade, Serbia
[2] Clin Ctr Serbia, Clin Nephrol, Belgrade, Serbia
[3] Univ Belgrade, Fac Med, Belgrade, Serbia
关键词
Antioxidants; end stage renal disease; ribonucleic acid; superoxide dismutase; LIPID-PEROXIDATION PRODUCTS; OXIDATIVE STRESS; DIALYSIS; PLASMA; CAPACITY; BLOOD; RNA;
D O I
10.4274/balkanmedj.2018.0170
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic renal failure, particularly end-stage renal disease, is a serious health problem associated with a high mortality rate. Uremic syndrome leads to increased oxidative stress, inflammation, and dyslipidemia. Aims: To examine superoxide dismutase isoenzyme gene expression in peripheral blood mononuclear cells of patients on hemodialysis and to determine the associations between superoxide dismutase isoenzyme gene expression, oxidative stress, and non-enzymatic antioxidative protection. Study Design: Case control study. Methods: This study included 33 patients on hemodialysis (age, 55.33 +/- 15.31 years old) and 33 apparently healthy controls (age, 45.37 +/- 8.92 years old). Superoxide dismutase isoenzyme messenger ribonucleic acid levels were determined by real-time polymerase chain reaction. General biochemical parameters, high sensitivity C-reactive protein, total antioxidant status, thiobarbituric acid-reactive substances, and the superoxide anion radical were also determined. Results: Normalized Cu/Zn superoxide dismutase and Mn superoxide dismutase messenger ribonucleic acid levels were significantly higher in patients than controls (p<0.001 and p=0.011). A significant negative correlation was detected between normalized Cu/Zn superoxide dismutase messenger ribonucleic acid levels and total protein total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and total antioxidant status. Normalized Mn superoxide dismutase messenger ribonucleic acid levels were negatively correlated with total protein and total antioxidant status. A multiple regression analysis revealed independent associations between total antioxidant status and normalized Cu/Zn superoxide dismutase (p=0.038) and between total antioxidant status and normalized Mn superoxide dismutase messenger ribonucleic acid levels (p=0.038 and p=0.018, respectively). Conclusion: The superoxide dismutase isoenzyme gene is expressed at a higher rate in patients with end-stage renal failure, probably due to increased oxidative stress and attenuated antioxidative defense. The plasma total antioxidant status is an independent predictor of normalized superoxide dismutase isoenzyme messenger ribonucleic acid levels.
引用
收藏
页码:431 / 436
页数:6
相关论文
共 29 条
[1]   mRNA study on Cu/Zn superoxide dismutase induction by hemodialysis treatment [J].
Akiyama, S ;
Inagaki, M ;
Tsuji, M ;
Gotoh, H ;
Gotoh, T ;
Gotoh, Y ;
Oguchi, K .
NEPHRON CLINICAL PRACTICE, 2005, 99 (04) :C107-C114
[2]  
Auclair C., 1985, HDB METHODS OXYGEN R
[3]  
Bland JM, 1996, BRIT MED J, V312, P1079
[4]  
CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]   Immune Dysfunction in Uremia-An Update [J].
Cohen, Gerald ;
Hoerl, Walter H. .
TOXINS, 2012, 4 (11) :962-990
[7]   Influence of dialysis on plasma lipid peroxidation products and antioxidant levels [J].
Daschner, M ;
Lenhartz, H ;
Botticher, D ;
Schaefer, F ;
Wollschlager, M ;
Mehls, O ;
Leichsenring, M .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1268-1272
[8]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[9]   A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation [J].
Erel, O .
CLINICAL BIOCHEMISTRY, 2004, 37 (04) :277-285
[10]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119